You searched for: "spiriva for sale visit drive-in.co.za"
European Chemicals Agency (ECHA) adds nine chemicals to the Candidate List of substances of very high concern (SVHC); six have been listed for intentional use or measured in food contact articles; listing obligates producers and suppliers to provide safety information and to notify ECHA; candidate list now contains 233 substances
Innovate UK seeks applications from UK businesses, institutions, charities, etc. to fund ambitious projects addressing UK Plastic Pact targets; project foci include: minimization/reduction of plastic packaging, food grade recycled polypropylene and polyethylene, and packaging suitable for reuse, refill; application open until September 8, 2021
Bureau of Indian Standards publishes draft update to standard for ionomer resins in contact with foodstuffs, pharmaceuticals, and drinking water; accepting comments on the proposal until December 6, 2022
Stakeholders from the food packaging industry discuss food safety issues, report strategies how to increase food safety
Government authority announces planned survey of food contact materials (FCMs) to test for presence of bisphenol A (BPA); results to be used to develop regulatory framework including maximum allowable content, leaching limits, tolerable daily intake
EU amends plastic FCM regulation; adjusts specific migration limits for five phthalates; removes authorized use of two FCMs; adds five new authorized substances; came into force on August 1, 2023
Sets definitions for 58 terms including “plastic”, “biodegradable plastic”, “composite”, and “polymer”; also defines process to mark and identify biobased materials; standard to become effective on June 1, 2021
FH Campus Wien publishes third edition of its Circular Packaging Design Guideline; provides recommendations for designing recyclable packaging; updated to reflect new legal and structural framework conditions, country-specific details
European Food Safety Authority (EFSA) publishes opinion on the impact of non-monotonic dose responses (NMDRs) on human health risk assessment; if NMDR may be present, suggests further testing at the low end of the dose-response curve; recommends developing internationally agreed guidance and harmonized frameworks for ‘identifying and addressing’ NMDRs during risk assessments
